@MysorekarLab
Account based inUnited States
About this account
- Account based in
- United States
- Connected via
- United States Android App
Account-level information from X, not a live location or the device used for a specific post.
Professor & Chief, Infectious Diseases, Passionate about research in #UTIs #viralInfections #autophagy #bladder #placenta #aging #immunity #translationalres
Houston, TX
Joined August 2017
- Tweets7.8K
- Following2.1K
- Followers2.6K
- Likes21.8K
Dr. Indira Mysorekar retweeted
The @NIH has ended continuous submission. The new policy gives two extra calendar weeks from the submission deadline if you have a study section or SEP as a reviewer within 4 weeks before or after a regular deadline, or serve on an NIH advisory council
grants.nih.gov/grants/guide/…
Dr. Indira Mysorekar retweeted
The next Uro-Aging RIG Knowledge Exchange will feature Aruna Sarma, PhD, MHA (University of Michigan) who will present "Urologic Complications in Diabetes- Long term findings."
More information: buff.ly/PAiV1fy
Dr. Indira Mysorekar retweeted
Dr. Rafael T. Michita @Michita_Rafael, BCM's @statnews Wunderkind, shares that path that is leading him to a successful career, @bcmhouston @MysorekarLab @BCMDeptMedicine #BCMPostdoc blogs.bcm.edu/2025/10/23/fro…
Dr. Indira Mysorekar retweeted
2025 BCM STAT #Wunderkind @Michita_Rafael talks about his groundbreaking research on maternal-fetal viral transmission #ZikaVirus tinyurl.com/5pezvech @bcmhouston @statnews #BCMPostdoc @MysorekarLab
Dr. Indira Mysorekar retweeted
I’m beyond honored to be named one of 🎉 STAT 2025 Wunderkinds.
Endless thanks to my mentor @MysorekarLab, labmates, and everyone who believed in this mission long before it had a name. The best is yet to come! #STATWunderkinds @statnews @BCMDeptMedicine
Congratulations, Dr. Rafael Tomoya Michita @Michita_Rafael, BCM's 2025 Wunderkind! #BCMPostdoc @MysorekarLab @statnews @BCMDeptMedicine @bcmhouston #ZikaVirus bcm.edu/news/dr-rafael-tomoy…
Dr. Indira Mysorekar retweeted
This past Friday, our SEA Fellows had the opportunity to learn from Sangeeta K. Cheema, JD, PhD, Intellectual Property Attorney.
In this lecture, Dr. Cheema provided a breakdown of the key steps in preparing biotechnology patent applications & strategic IP portfolio management.
Dr. Indira Mysorekar retweeted
Faculty like Drs. @deepaksharma248 @Michita_Rafael @MysorekarLab and Long Tran inspire our work in CME.
@BCMFromtheLabs shared their review on virus spread in placenta: bit.ly/48fcVrP
Once done reading, explore related topics on BCM CR: clinicianresources.bcm.edu/l…
@BCMDeptMedicine
Interested in how #viruses spread in the #placenta? L Tran, @Michita_Rafael, @deepaksharma248 & @MysorekarLab just published a #review on this topic. sciencedirect.com/science/ar… #CurrOpinionVirol @BCMDeptMedicine @BCMGradSchool
Dr. Indira Mysorekar retweeted
Interested in how #viruses spread in the #placenta? L Tran, @Michita_Rafael, @deepaksharma248 & @MysorekarLab just published a #review on this topic. sciencedirect.com/science/ar… #CurrOpinionVirol @BCMDeptMedicine @BCMGradSchool
Dr. Indira Mysorekar retweeted
Learn how to protect your innovations and navigate patents & licensing on Oct 3 for the Scientific Entrepreneurship Academy's session, IP Basics for Entrepreneurs, led by industry expert Sangeeta K. Cheema, JD, PhD.
Interested in attending? Contact us at [email protected]!
Dr. Indira Mysorekar retweeted
HAPPENING TODAY- CAIRIBU's Uro-Aging Research Interest Group commences!
The Uro-Aging Research Interest Group (UroAging RIG) will connect uro-aging interested CAIRIBU and non-CAIRIBU investigators from a variety of fields including but not limited to urology, urogynecology, and geroscience. To kick-start this group, we are scheduling monthly knowledge exchanges to know each other, discuss recent research, develop collaborations, and strategize on ways to advance uro-aging research.
Join our first knowledge exchange on Monday, September 22 at 3:00 PM ET to hear from Indira Mysorekar, PhD (Baylor College of Medicine) and Scott Bauer, MD, MS (University of California, San Francisco) who will kick off this series by reviewing the field of uro-aging research and stimulating discussion on a collaborative, interdisciplinary research agenda.
More info: buff.ly/79b86Xf
Dr. Indira Mysorekar retweeted
Circular RNAs accumulate in aging human placental tissue and in stillbirth, leading to DNA damage and cellular senescence ow.ly/IkGH50WOw4L
Dr. Indira Mysorekar retweeted
This morning, our SEA Fellows heard from the incredible Eric Schaefer, Senior Director, Portfolio Strategy & Investment at @MarchofDimes.
Eric aided our fellows in understanding how to navigate different types of funding strategies & how to pitch their innovation to investors.
Dr. Indira Mysorekar retweeted
This is HUGE!
No embargo needed for @AACR publications deposited in PubMed Central - enabling compliance with the NIH public access policy without spending exorbitant open access fees.
You can read the AACR journals' policy here: aacrjournals.org/pages/open-… "The Author Accepted Manuscript is permitted to be deposited in PMC and made available to the public on or after the first online publication date of the Version of Record."
Dr. Indira Mysorekar retweeted
Tissue immunity meets biological sex differences - context is important in the immune system. Another of my reading recommendations during a trip to @iuis_online Congress. From Sonia Sharma, Alicia Gibbons and @EOSaphire in @ScienceMagazine
buff.ly/XPN0Tpb
Dr. Indira Mysorekar retweeted
Have You Read This?
"A scalable organoid model of urothelial aging for metabolic interrogation, infection modeling, and reversal of age-associated changes"
Read it: pubmed.ncbi.nlm.nih.gov/4063…
Read more like it: cairibu.urology.wisc.edu/hyr…
Dr. Indira Mysorekar retweeted
🚨🚨ATTENTION TO OUR FRIENDS DOWN UNDER 🦘🇦🇺🐨
@MonashUni will be hosting an in-person and virtual symposium on bladder and kidney health 10/24/25!
Many #UTIGA members will be speaking and attending. This will be a great opportunity to network and learn 💖
@ChronicUTIAus
Dr. Indira Mysorekar retweeted
AUA’s @drrachelrubin recently joined an FDA panel to advocate for removing the FDA black box warning on low-dose vaginal estrogen. We stand with Dr. Rubin and the broader medical community for the removal of this outdated label that undermines safe, effective care for women with GSM. #AUAadvocacy
Learn more 👉 bit.ly/3UL6jcu
Dr. Indira Mysorekar retweeted
Here is the bill approved today by the senate committee. 🤞for next steps. appropriations.senate.gov/im…
Dr. Indira Mysorekar retweeted
This just in… FY’26 Bill Highlights:
National Institutes of Health: $48.7 billion for biomedical investments in research.
Cancer: $7.4 billion for the National Cancer Institute, including $28 million for the Childhood Cancer STAR Act.
statnews.com/2025/07/31/nih-…
Dr. Indira Mysorekar retweeted
Senate HELP committee endorses @NIH budget increase, rebuking Trump administration’s proposed 40% cut. 🙏 statnews.com/2025/07/31/nih-… via @statnews